Pharmaceuticals

The Medicines Company announced the approval of cangrelor (Kengreal) by the U.S. Food and Drug Administration (FDA) as an adjunctive therapy to percutaneous coronary intervention (PCI). The novel, intravenous antiplatelet...

A risk assessment algorithm combining clinical risk factors and platelet function test results may help interventional cardiologists better identify patients who stand to benefit from intensive antiplatelet medication after percutaneous coronary i...

People with acute coronary syndrome (ACS) who undergo an angioplasty procedure and receive a heart stent are prescribed an oral antiplatelet (OAP) therapy and aspirin to help prevent a heart attack, a blood clot in their heart stent (stent thrombo...

The Medicines Company announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 9 - 2 with one abstention to recommend approval of the investigational intravenous antiplatelet agent...

idarucizumab, dabigatran, anticoagulant, Boehringer Ingelheim, RE-VERSE AD
Results from an interim analysis of the Phase III RE-VERSE AD patient study demonstrate that 5 g of idarucizumab immediately reversed the anticoagulant effect...
ACC, Statin Intolerance App, statin therapy, muscle symptoms, pain
The American College of Cardiology (ACC) Statin Intolerance App is now available to help guide clinicians through the process of managing and treating patients...
cangrelor, Kangreal, FDA approval, The Medicines Company, antiplatelet agent
The Medicines Company announced the approval of cangrelor (Kengreal) by the U.S. Food and Drug Administration (FDA) as an adjunctive...
VHA, dabigatran, patient adherence, JAMA, Mintu Turakhia
Atrial fibrillation patients on the anticoagulant dabigatran were more likely to adhere to the medication with appropriate patient selection and pharmacist-led...
ACC, Statin Intolerance App, statin therapy, muscle symptoms, pain
The American College of Cardiology (ACC) Statin Intolerance App is available to help guide clinicians through the process of managing and
Lumify is the first app-based ultrasound solution from Philips that will extend the reach of ultrasound applications across the health...
Agfa HealthCare's Xero Viewer now features Full Fidelity View for diagnostic viewing. The functionality uses lossless compression to...
Pie Medical Imaging's CAAS MRV software is now enabled for analysis of the heart to support diagnosis of cardiovascular conditions. The...

Articles

cangrelor, Kangreal, FDA approval, The Medicines Company, antiplatelet agent
The Medicines Company announced the approval of cangrelor (Kengreal) by the U.S. Food and Drug Administration (FDA) as an adjunctive...
Brilinta, Ticagrelor, PEGASUS TIMI-54, ACC, results
AstraZeneca announced full results from the PEGASUS-TIMI 54 study, a large-scale outcomes trial investigating Brilinta (ticagrelor) tablets plus low dose...
antiplatelet medication, prasugrel, clopidogrel, risk algorithm, SCAI
A risk assessment algorithm combining clinical risk factors and platelet function test results may help interventional cardiologists better identify patients...
PROMETHEUS, prasugrel, clopidogrel, heart disease, bleeding, SCAI
Prasugrel (Effient) is more likely to be given to lower-risk heart disease patients undergoing percutaneous coronary intervention (PCI) compared to clopidogrel...

Video Center

Here are a few observations on cardiovascular ultrasound advances I made while attending the 2015...
1 week 1 day ago
The latest advances in cardiovascular echocardiography will be presented at the 2015 American...
3 weeks 4 days ago
There were several technology takeaway messages for the future of electrophysiology (EP) at the...
6 weeks 4 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...

Comparison Charts

Sorry there is no data available